GPT and metabolic dysfunction-associated steatotic liver disease: This result was similar to previous findings on liver enzymes, in which MAFLD was associated with higher levels of ALT and AST and a higher risk for fibrosis compared with NAFLD, and MAFLD was superior to NAFLD in identifying adverse liver outcomes [6].